Hybrid methodology of online panel and telephonic discussions was conducted with the mCRC (Metastatic Castration-Resistant Prostate Cancer) patients and their caregivers.
The sample of 400 was achieved through the internal panel, patient advocacy groups and online support groups
Length of Interview: 25 minutes
Target countries: United Kingdom, France, Italy and Spain
We deployed a specialist team of healthcare researchers, comprised of experienced Healthcare Research Analyst with primary, desk and data analysis skills.
Data was delivered in SPSS/ Excel and brief PPT report with topline highlights.
Final output provided real-time insights from patients and caregivers on the current care pathway and associated challenges across physicians and pharmaceutical marketers.
The insights assisted the client to offer recommendations to the pharmaceutical sponsor for revamping their product messaging and improve the existing engagement model.